This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, The Simons Center for Systems Biology at the Institute for Advanced Study. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025-2026
Title: Vinod P Balachandran: Innovator in Cancer Treatment
Introduction
Vinod P Balachandran is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. His work focuses on the development of systems and methods that enhance the effectiveness of immunotherapy for cancer patients.
Latest Patents
Vinod P Balachandran holds a patent for "Neoantigens and uses thereof for treating cancer." This patent outlines systems and methods for determining the likely responsiveness of a human cancer subject to a checkpoint blockade immunotherapy regimen. The process involves obtaining sequencing reads from cancer samples, determining human leukocyte antigen types, and computing clone fitness scores based on neoantigens. This innovative approach aims to quantify the responsiveness of cancer subjects to immunotherapy regimens.
Career Highlights
Throughout his career, Balachandran has worked with esteemed institutions, including the Icahn School of Medicine at Mount Sinai. His research has contributed to advancing the understanding of cancer treatment and improving patient outcomes.
Collaborations
Vinod P Balachandran has collaborated with notable colleagues, including Marta Luksza and Arnold J Levine. These partnerships have fostered a collaborative environment that enhances the research and development of cancer therapies.
Conclusion
Vinod P Balachandran's innovative work in cancer treatment exemplifies the impact of research and patents in advancing medical science. His contributions continue to pave the way for improved therapies and better patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile